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ABSTRACT
Background Mild parkinsonian signs are important 
clinical symptoms related to the decline of motor and 
cognitive functions. We aimed to identify predic-
tors for the incidence of mild parkinsonian signs in 
older Japanese by conducting an 8-year longitudinal 
community-based cohort study.
Methods Participants aged 65 years or older, living in 
Ama-cho, a rural island town in western Japan, under-
went a baseline assessment of motor function, cognitive 
function, depression score, the Pittsburgh Sleep Quality 
Index (PSQI), the Tanner questionnaire, and cerebral 
white matter lesions on brain magnetic resonance imag-
ing from 2008 to 2010, and then underwent a follow-up 
neurological examination from 2016 to 2017. Mild par-
kinsonian signs were defined according to a modified 
Unified Parkinson’s Disease Rating Scale score.
Results Of the 316 participants without mild par-
kinsonian signs at baseline, 94 presented with incident 
mild parkinsonian signs at follow-up. In addition to an 
absence of exercise habits, a higher score on the Tanner 
questionnaire, PSQI, and deep white-matter hyperin-
tensity Fazekas scores were significant independent 
predictors for incidence of mild parkinsonian signs.
Conclusion We suggest multiple factors related to 
incidence of mild parkinsonian signs. Vascular lesions 
and sleep disorders are associated with a pathogenesis 
of mild parkinsonian signs, the Tanner questionnaire 
is useful for early detection of subclinical mild parkin-
sonian signs, and exercise has a possibility of being 
associated with preventing onset of mild parkinsonian 
signs.
Key words cerebral white matter lesions; exercise 
habits; sleeping disorder; subjective motor symptoms
Mild parkinsonian signs (MPS) are defined as features 
of bradykinesia, rigidity, and tremor, in addition to gait 
and postural instability occurring in isolation or combi-
nations that do not meet clinical criteria for a diagnosis 
of parkinsonism. MPS are common in aging with their 
prevalence ranging from 15% to 52%.1–3 Subjects with 
MPS have more cerebral white matter lesions than those 
without.4–6 MPS is known to have the same risk factors 
as Parkinson’s disease, such as depression, hyposmia, 
REM sleep behavior disorder, and substantia nigra 
hyperechogenicity.3, 7, 8 Neuropathological changes of 
MPS have not yet been fully elucidated. Heterogeneous 
pathological changes, such as age related decline in ni-
grostriatal dopaminergic neurons, degenerative changes 
of Lewy body or Alzheimer’s disease, and vascular 
changes in the cerebral subcortical white matter, prob-
ably relate to MPS.9
MPS are associated with increased incidence 
of dementia10, 11 as well as functional disability such 
as parkinsonism12, 13 and mortality,14 although these 
can be reversible.15 We have previously reported that 
the presence of MPS is a risk factor for the develop-
ment of parkinsonism and dementia in a prospective 
community-based cohort study.16 MPS are thought to be 
an important clinical sign in aging, and it is important 
to prevent the incidence of MPS at an early stage to 
extend healthy life expectancy. Here, we report an 
8-year follow-up in our cohort to identify predictors for 
incident MPS in older community-dwelling Japanese.
SUBJECTS AND METHODS
Participants
We conducted this study in the municipality of Ama-
cho, a rural island town with a large older population 
located 70 km from Yonago city, in the northwestern 
part of Japan.3 To be eligible for the study, participants 
were required to be physical and legal residents of the 
town on March 31, 2008. Inclusion criteria were as fol-
lows: (i) 65 years of age or older (n = 731), (ii) agreement 
to participate in the study, and (iii) completion of an 
examination survey at baseline and follow-up. Exclusion 
criteria were as follows: (i) participants who had died or 
moved out of town, (ii) participants who had a medical 
history of psychiatric disorders, and (iii) participants 
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with severe organ dysfunction. Participants who did not 
undergo this survey despite our vigorous and repeated 
appeals prompting their participation were classified as 
nonresponders.
The study was approved by the Tottori University 
Committee for Medical Research Ethics (approval 
No. 1695) and followed the principles outlined in the 
Declaration of Helsinki and its contemporary amend-
ments. All participants provided their written informed 
consent to participate.
Survey procedure and data collection
This study design was a prospective longitudinal study. 
The baseline study was conducted from 2008 to 2010 
and the follow-up study was from 2016 to 2017. We 
conducted a uniform and standardized examination pro-
gram at baseline and 8 years later. We first administered 
a questionnaire survey by mailing the questionnaires 
to the residents legally living in Ama-cho at the start 
of the baseline and follow-up study, and subsequently 
conducted an examination survey.
Questionnaire survey
The questionnaire was constructed to collect personal 
information and demographic information such as age, 
sex, formal education level, medical history including 
hypertension, dyslipidemia, diabetes mellitus, and 
current exercise habits. Medical history data were also 
obtained via a review of electronic healthcare system 
databases and patient administered questionnaires. 
For assessments of subjective motor and nonmotor 
symptoms of the participants, we also administered 
the Tanner questionnaire, which is validated for 
Parkinson’s disease screening.17 The Japanese version 
of the Geriatric Depression Scale (GDS) with 15 ques-
tions, which has been validated for the diagnosis of 
depression,18 was administered to evaluate symptoms of 
depression. We administered the REM Sleep Behavior 
Disorder Screening Questionnaire (RBDSQ) to assess 
REM sleep behavior disorder,19 and the Pittsburgh 
Sleep Quality Index (PSQI), which evaluates quality 
of sleep.20 GDS, RBDSQ, and PSQI were evaluated by 
the real number of scores, not by grouping by cut-off, 
in order to capture the effects of minor changes. The 
presence of constipation, hyposmia, and orthostatic 
hypotension was obtained by a self-administered 
questionnaire in which participants were asked if they 
experienced these symptoms or not.
Examination survey
Neurologists conducted a standardized neurological 
examination including an abbreviated (10-item) version 
of the motor portion of the Unified Parkinson’s Disease 
Rating Scale (modified UPDRS). The mUPDRS is able 
to diagnose parkinsonian signs in older community-
dwelling people.3, 10, 21 The 10 item scale (each item 
rated from 0 to 4) assessed speech, facial expression, 
tremor at rest, rigidity (rated separately in the neck, right 
arm, left arm, right leg, and left leg), posture, and body 
(axial) bradykinesia. A Mini-Mental State Examination 
(MMSE) was administered to assess global cognitive 
function.22 We performed routine examinations in 
community centers and visited individual houses and 
nursing homes to raise participant rates in those who 
would otherwise have difficulty participating.
Assessment of cerebral white-matter hyperintensi-
ties
In the baseline study, brain magnetic resonance (MR) 
imaging was performed between March 2010 and May 
2010, using a 1.5 T system (Philips Gyroscan Intera 1.5 
T, Philips, Tokyo, Japan).23 Fazekas scores were used to 
assess periventricular hyperintensity (PVH) and deep 
white-matter hyperintensity (DWMH).24
Diagnostic Criteria
Those participants who had 2 or more cardinal signs 
(mUPDRS rating ≥ 2) on the standardized neurological 
examination were classified as having parkinsonism. 
Participants were classified as having MPS when they 
had 2 or more mUPDRS ratings = 1, one mUPDRS rat-
ing ≥ 2, or an mUPDRS resting tremor rating ≥ 1.3, 7, 21 
Subtypes of MPS were classified as follows. Axial 
dysfunction: (1) UPDRS ratings = 1 in 2 or more of 
the 4 items of axial function (changes in speech, facial 
expression, posture, and axial bradykinesia), or (2) one 
UPDRS rating ≥ 2 on one of the 4 items. Rigidity: (1) 
UPDRS ratings = 1 in 2 or more of the 5 items of rigid-
ity, or (2) one UPDRS rating ≥ 2 on one of the 5 items. 
Tremor: UPDRS resting tremor rating ≥ 1. Mixed: 
combination of the above 2 or 3 subtypes.
Statistical analysis
Descriptive statistics for each baseline clinical char-
acteristic of normal individuals stratified by prognosis 
are given as the mean (standard deviation) for age and 
education, the median (quartile) for other noncategorical 
data, and the number (percentage) for categorical data. 
The variables age and education were analyzed using 
Student t test, other noncategorical variables using 
Mann–Whitney U test, and categorical variables using 
chi-squared test. Binary logistic regression analyses 
were conducted to determine predictors for incident 
MPS. Unadjusted univariate regressions were conducted 
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first, then multivariate regressions with a likelihood 
ratio test were conducted for the variables that had been 
found to be associated with incidence of MPS in the 
univariate regressions. A 2-tailed P < 0.05 was consid-
ered significant. All analyses were performed with IBM 




The flow of participants is presented in Fig. 1. Those 
participants having MPS (n = 168) or parkinsonism (n 
= 71) at baseline were excluded. Of the 492 remaining 
normal participants at baseline, 73 subjects were de-
ceased or had moved outside of the town at the time of 
the 8-year follow up. We lost 103 subjects to follow up 
as a result of withdrawal from study. Of 316 participants 
who were eligible for the present study, 187 remained 
motor-normal (persistent normal), 94 had developed 
MPS (incident MPS), and 35 had developed parkinson-
ism (incident parkinsonism). Participants who dropped 
out of the study were significantly older than those who 
completed the 8-year follow-up evaluation (data not 
shown).
Related factor of incidence of MPS
Baseline characteristics of the persistent normal group 
and the incident MPS group are presented in Table 1. 
Univariate analysis revealed that older age, not having 
an exercise habit, and a higher score for the Tanner 
questionnaire, GDS, RBDSQ, PSQI, or Fazekas 
(PVH and DWMH) assessments were associated with 
incidence of MPS. Binary logistic regression analysis 
adjusted for age and sex revealed that the absence of 
habitual exercise, the Tanner questionnaire score, PSQI 
score, and DWMH Fazekas score were significant 
independent predictors for incidence of MPS (Table 2). 
Participants who scored 2 points or more on the Tanner 
Questionnaire developed significantly more MPS than 
participants who scored 1 point or less (Fig. 2).
DISCUSSION
In the present study, we investigated the predictors for 
incidence of MPS in a longitudinal 8-year study of an 
older adult community. Multivariate analysis revealed 
that a higher score on DWMH Fazekas, PSQI, or Tanner 
questionnaire assessments, and the absence of habitual 
exercise at baseline were independently associated 
with onset of MPS. To our knowledge, these predictors 
Fig. 1. The flow of participants.
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have not been reported to date and only 2 studies have 
investigated other predictors of MPS; a longitudinal 
5-year study found that SN-hyperechogenicity and 
hyposmia were risk factors for predicting MPS,25 and 
a 1-year study found cardiovascular disease (any one of 
myocardial infarction, angina, arrhythmia, and chronic 
heart failure) predicted MPS.15 Several cross-sectional 
studies have found that cerebral white-matter lesions are 
associated with MPS.4–6 These previous studies proved 
that subjects with MPS have more cerebral small-vessel 
disease such as white-matter hyperintensities, lacunar 
infarctions, and cerebral microbleeds, suggesting that 





Age (year)* mean (SD) 72.1 (5.2) 74.2 (5.5)
Sex (women) n (%) 106 (56.7) 60 (63.8)
Education (year) mean (SD) 10.1 (2.2) 9.9 (2.1)
Exercise habits* n (%) 68 (38.9) 15 (17.2)
mUPDRS score median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Tanner questionnaire score* median (IQR) 0.0 (0.0–1.0) 1.0 (0.0–3.0)
MMSE score median (IQR) 28.0 (26.0–29.0) 27.5 (26.0–29.0)
GDS score* median (IQR) 2.0 (0.0–3.0) 3.0 (1.0–5.0)
RBDSQ score* median (IQR) 1.0 (0.0–3.0) 2.0 (1.0–3.8)
Constipation n (%) 28 (16.4) 18 (21.7)
Hyposmia n (%) 13 (7.3) 9 (10.6)
Orthostatic hypotension n (%) 24 (13.5) 19 (22.6)
PSQI score* median (IQR) 3.0 (2.0–4.0) 3.0 (2.0–5.0)
Hypertension n (%) 116 (62.0) 68 (72.3)
Dyslipidemia n (%) 54 (28.9) 30 (31.9)
Diabetes mellitus n (%) 25 (13.4) 18 (19.1)
PVH score* median (IQR) 1.0 (0.0–1.0) 1.0 (1.0–2.0)
DWMH score* median (IQR) 1.0 (1.0–2.0) 2.0 (1.0–2.0)
*Significant (P < 0.05) differences between individuals with persistent normal and incident MPS.
Table 2. Predictors for incident MPS
Unit of increase Univariate Multivariate
Age (year) 1 year 1.08 (1.03–1.13)* –
Sex (women) 0 = men 
1 = women
0.74 (0.45–1.24)
MMSE score 1 score 0.95 (0.85–1.06)
Exercise habits 0 = absent 
1 = present
0.33 (0.17–0.62)* 0.42 (0.21–0.86)*
Tanner questionnaire score 1 score 1.59 (1.33–1.92)* 1.45 (1.19–1.78)*
GDS score 1 score 1.18 (1.07–1.30)* –
RBDSQ score 1 score 1.21 (1.04–1.40)* –
PSQI score 1 score 1.14 (1.03–1.26)* 1.19 (1.06–1.35)*
PVH score 1 score 1.51 (1.11–2.05)* –
DWMH score 1 score 1.80 (1.31–2.47)* 1.62 (1.12–2.34)*
Odds ratio (95% CI) is indicated. *P < 0.05
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vascular mechanisms are a key pathophysiology of 
MPS. Previously, we reported that higher DWMH and 
PVH Fazekas scores were associated with the progres-
sion of parkinsonian signs of MPS subjects at 3 years.16 
Our present study shows that a higher DWMH Fazekas 
score at baseline is associated with the onset of MPS 
from normal within 8 years. By contrast, there were no 
significant associations between vascular risk factors 
such as hypertension, dyslipidemia, and diabetes and 
the onset of MPS. Taken together with our results, 
vascular pathological changes in cerebral white matter 
are key contributors to incidence of MPS or prognosis 
of parkinsonism in the older adults.
Our present study also showed that a higher 
PSQI score is an independent predictor for incident 
MPS. It was unclear whether the presence of sleeping 
disorders meeting the criteria for PSQI score cutoff (≥ 
6) significantly related to the onset of MPS, because 
few participants met the criteria. In the present study, 
participants with PSQI scores of 1 to 3 (mild sleeping 
disturbance) comprised the majority. Sleeping disorder 
and motor dysfunction are both common conditions in 
old age, and causal relationship between the 2 clinical 
symptoms is complex. There is a question of whether 
mild sleeping disorder is a risk factor for onset of MPS 
or is a prodromal symptom of MPS. Lysen et al. have 
shown that worse sleep quality and shorter sleep dura-
tion relate to a higher risk of parkinsonism including 
Parkinson’s disease in a prospective population-based 
study, but that this increased risk disappears with longer 
follow-up.26 They have argued that in the general popu-
lation, sleep disturbances are markers of the prodromal 
phase of parkinsonism. In any case, conducting further 
interventional studies on sleep and the risk of develop-
ing MPS is warranted.
It is important to detect MPS at risk at an early 
stage, and follow them carefully. The Tanner question-
naire assesses the subjective motor symptoms of the 
participants and has been validated for screening for 
Parkinson’s disease. Our present study showed that a 
higher Tanner questionnaire score is associated with 
onset of MPS. In particular, participants who scored 
2 or more developed significantly more MPS than 
participants who scored 1 or less. We suggest that the 
Tanner questionnaire is useful for screening to detect 
subclinical MPS in risk groups. Those who are aware of 
a decline in motor function subjectively could possibly 
develop a movement disorder within a few years, even 
if their parkinsonism cannot be identified objectively 
at baseline. Mitchell et al. have reported that subjective 
cognitive decline is a risk factor for objective cogni-
tive decline.27 Just as there is a subjective cognitive 
impairment as a prodromal stage of mild cognitive 
impairment, there may be a similar stage before MPS. 
Subjective symptoms are therefore considered important 
for early detection of MPS, and additional investigation 
is needed that follows up or intervenes by targeting 
participants with subjective symptoms alone.
We also found that an absence of exercise habits 
at baseline was significantly associated with onset of 
MPS. Higher levels of physical activity may lower 
the risk of Parkinson’s disease, especially in men.28 
There have been no reports of longitudinal studies of 
the association between exercise and MPS to date. 
This study showed that exercise is possibility associ-
ated with preventing onset of MPS. We propose some 
mechanistic hypotheses by which exercise indirectly 
prevents MPS, perhaps by preventing lifestyle disease 
and consequently preventing white matter lesions, or 
perhaps exercise prevents MPS by another mechanism 
such as maintenance of skeletal muscle, or prevents 
degenerative mechanisms, especially in those with a 
predisposition to MPS who tended to avoid exercise in 
the early years before onset. Further studies involving 
quantitation of exercise or exercise intervention will 
be needed to clarify the diverse relationships between 
exercise and MPS.
The present study has a few limitations. First, 
although we were able to investigate the entire popula-
tion over the age of 65 on Ama-cho, there were 103 
Fig. 2. Development of mild parkinsonian signs (MPS) by 
Tanner score at baseline. Participants who scored 2 points or more 
on the Tanner Questionnaire developed significantly more MPS 
than participants who scored 1 point or less (chi-squared test).
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non-responders at the time of follow-up, and the non-
responders were significantly older and could cause se-
lection bias in the analysis. Second, we did not evaluate 
MPS as it developed over the 8 year period. Our present 
study should be replicated with higher response rates 
and an analysis including time of onset.
In conclusion, we found vascular lesions and sleep 
disorders were associated with the underlying pathogen-
esis of onset of MPS, the Tanner questionnaire was use-
ful for early detection of subclinical symptoms of MPS, 
and exercise is possibly associated with preventing the 
onset of MPS. It is necessary to identify individuals 
with high risk of MPS and prevent onset of MPS by 
modifying their lifestyle. However, whether MPS is 
preventable or not requires further research.
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